Efficacy and Safety of Peginterferon in ET and PV.

Abroad (travel likely)Recruiting

Conditions

Essential Thrombocythemia · Polycythemia Vera

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Contact: Study coordinator (ZhenYa Hong) · hongzhenya@126.com · 13476158466

Study leads

ZhenYa Hong, Ph.D
Principal Investigator
Tongji Medical College, Huazhong University of Science and Technology

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Myelofibrosis; Anemia · Anemia · Myelofibrosis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gilbert, United States · Duarte, United States

A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

Polycythemia Vera · Thrombocythemia

Abroad (travel likely)Recruiting

Rochester, United States · Halle, Germany

Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis

Primary Myelofibrosis (PMF) · Post-polycythemia Vera Myelofibrosis (Post-PV MF) · Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)

Abroad (travel likely)RecruitingPHASE1

Kamogawa, Japan · Sapporo, Japan

Research Platform Myelofibrosis and Anemia

Primary Myelofibrosis · Secondary Myelofibrosis · Post-polycythemia Vera Myelofibrosis

Abroad (travel likely)Recruiting

Multiple Locations, Germany